Return
Company Page
AbInitio Bio
Founders
AbInitio Bio is an AI-driven biomanufacturing intelligence platform building frontier foundation models validated against wet lab data. Its first model, Echo, predicts manufacturing outcomes for pharma and CDMO partners, enabling process decisions in hours that traditionally take 6 to 18 months. The company is a Y Combinator Spring 2026 (P26) graduate, an MIT R2E program selectee, and a Fifty Years 5050 program company.
Company Founded in 2026
